Aiming for the Cure in <i>ERBB2</i>-Positive Metastatic Breast Cancer—Should We Go “All In”?—Reply
Paolo Tarantino, Heather A. Parsons, Sara M. Tolaney
Abstract
In Reply We read with keen interest the comments from Drs Rala de Paula and Crocamo on our Review discussing strategies to improve long-term outcomes for ERBB2-positive metastatic breast cancer (MBC).1
Topics & Concepts
MedicineMetastatic breast cancerOncologyBreast cancerInternal medicineCancerAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchCancer-related Molecular Pathways